Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Blue Jet Healthcare Ltd.

Pharmaceuticals & Drugs

Rating :

N/A

BSE: 544009 | NSE: BLUEJET

Watchlist

NSE BSE

564.25

20-Dec-2024

Open
High
Low
Previous Close

590.30
590.30
559.65
580.45

Volume
Traded Value (lacs)
52 Week High
52 Week Low

472816
2711.39
603.00
324.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

9,780.85
58.26
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

9,694.86
0.18%
10.59

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
1.35

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-1.66

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-3.39

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

-
-
-

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
-

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 9.44 12.76 15.78 18.86
P/E Ratio 55.41 41 33.15 27.73
Revenue 708 894 1096 1342
EBITDA 229 292 369 440
Net Income 164 221 274 327
ROA 17.1 19.4 19.1 18.3
P/Bk Ratio 10.73 8.7 7.16 5.95
ROE 21.45 30.17 27.94 21.25
FCFF 68.83 -18.93 68 164.68
FCFF Yield 0.78 -0.22 0.77 1.87

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 208.26 181.35 14.84% 162.90 0.00 0 183.94 0.00 0 166.76 0.00 0
Expenses 138.77 118.73 16.88% 118.64 0.00 0 130.88 0.00 0 112.18 0.00 0
EBITDA 69.49 62.62 10.97% 44.26 0.00 0 53.07 0.00 0 54.58 0.00 0
EBIDTM 33.37% 34.53% 27.17% 0.00% 28.85% 0.00% 32.73% 0.00%
Other Income 12.07 8.21 47.02% 8.71 0.00 0 8.83 0.00 0 6.75 0.00 0
Interest 0.02 0.04 -50.00% 0.03 0.00 0 0.03 0.00 0 0.04 0.00 0
Depreciation 4.62 6.47 -28.59% 3.48 0.00 0 7.72 0.00 0 7.85 0.00 0
PBT 76.92 64.33 19.57% 49.47 0.00 0 54.15 0.00 0 43.70 0.00 0
Tax 18.57 16.46 12.82% 11.69 0.00 0 14.50 0.00 0 11.59 0.00 0
PAT 58.35 47.87 21.89% 37.78 0.00 0 39.65 0.00 0 32.11 0.00 0
PATM 28.02% 26.40% 23.19% 0.00% 21.56% 0.00% 19.25% 0.00%
EPS 3.36 2.76 21.74% 2.18 0.00 0 2.29 0.00 0 1.85 0.00 0

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21
Net Sales - 711.60 720.98 683.47 498.93 Net Sales Growth - -1.30% 5.49% 36.99% Cost Of Goods Sold - 314.40 335.96 287.45 169.45 Gross Profit - 397.20 385.02 396.01 329.48 GP Margin - 55.82% 53.40% 57.94% 66.04% Total Expenditure - 482.37 501.89 434.20 292.08 Power & Fuel Cost - 24.56 32.99 27.25 19.91 % Of Sales - 3.45% 4.58% 3.99% 3.99% Employee Cost - 53.19 41.90 33.03 28.95 % Of Sales - 7.47% 5.81% 4.83% 5.80% Manufacturing Exp. - 33.19 35.44 64.61 53.37 % Of Sales - 4.66% 4.92% 9.45% 10.70% General & Admin Exp. - 13.86 12.49 5.23 8.11 % Of Sales - 1.95% 1.73% 0.77% 1.63% Selling & Distn. Exp. - 19.64 27.27 5.56 4.20 % Of Sales - 2.76% 3.78% 0.81% 0.84% Miscellaneous Exp. - 23.54 15.85 11.08 8.07 % Of Sales - 3.31% 2.20% 1.62% 1.62% EBITDA - 229.23 219.09 249.27 206.85 EBITDA Margin - 32.21% 30.39% 36.47% 41.46% Other Income - 28.86 23.96 19.41 8.61 Interest - 0.16 1.36 3.30 5.31 Depreciation - 28.09 25.07 22.15 19.66 PBT - 229.84 216.61 243.23 190.49 Tax - 56.34 56.58 61.64 48.87 Tax Rate - 25.60% 26.12% 25.34% 25.65% PAT - 163.75 160.03 181.59 141.62 PAT before Minority Interest - 163.75 160.03 181.59 141.62 Minority Interest - 0.00 0.00 0.00 0.00 PAT Margin - 23.01% 22.20% 26.57% 28.38% PAT Growth - 2.32% -11.87% 28.22% EPS - 9.44 9.22 10.47 8.16

Description TTM Mar 21
Net Sales - 498.93 Net Sales Growth - Cost Of Goods Sold - 169.45 Gross Profit - 329.48 GP Margin - 66.04% Total Expenditure - 292.88 Power & Fuel Cost - 19.91 % Of Sales - 3.99% Employee Cost - 28.95 % Of Sales - 5.80% Manufacturing Exp. - 53.37 % Of Sales - 10.70% General & Admin Exp. - 8.11 % Of Sales - 1.63% Selling & Distn. Exp. - 4.20 % Of Sales - 0.84% Miscellaneous Exp. - 8.87 % Of Sales - 1.78% EBITDA - 206.05 EBITDA Margin - 41.30% Other Income - 8.88 Interest - 5.31 Depreciation - 19.66 PBT - 189.96 Tax - 48.87 Tax Rate - 26.47% PAT - 138.42 PAT before Minority Interest - 135.79 Minority Interest - 2.63 PAT Margin - 27.74% PAT Growth - EPS - 7.98

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Shareholder's Funds 845.22 681.49 521.54 339.82 Share Capital 34.69 34.69 34.69 9.91 Total Reserves 810.53 646.79 486.85 329.91 Non-Current Liabilities 7.66 6.70 17.33 33.35 Secured Loans 0.00 0.00 0.00 28.67 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 4.12 4.13 3.77 3.29 Current Liabilities 361.59 318.42 259.07 220.05 Trade Payables 30.30 53.78 56.55 59.53 Other Current Liabilities 50.55 38.66 32.35 46.12 Short Term Borrowings 0.00 0.00 0.00 7.13 Short Term Provisions 280.74 225.98 170.17 107.27 Total Liabilities 1,214.47 1,006.61 797.94 593.22 Net Block 171.94 151.04 156.48 138.92 Gross Block 275.57 230.56 214.58 176.03 Accumulated Depreciation 103.64 79.52 58.10 37.11 Non Current Assets 353.21 197.02 165.03 146.25 Capital Work in Progress 147.06 30.46 3.43 2.58 Non Current Investment 15.00 0.00 0.00 0.00 Long Term Loans & Adv. 18.98 15.34 5.02 4.66 Other Non Current Assets 0.24 0.17 0.10 0.08 Current Assets 861.26 809.59 632.70 446.97 Current Investments 235.49 189.28 93.77 36.84 Inventories 129.84 125.66 105.03 117.72 Sundry Debtors 176.93 239.38 227.44 144.00 Cash & Bank 84.71 65.63 87.66 70.45 Other Current Assets 234.30 18.13 8.21 4.20 Short Term Loans & Adv. 218.81 171.52 110.58 73.77 Net Current Assets 499.67 491.17 373.63 226.93 Total Assets 1,214.47 1,006.61 797.73 593.22

Description Mar 21
Shareholder's Funds 339.82 Share Capital 9.91 Total Reserves 329.91 Non-Current Liabilities 33.35 Secured Loans 28.67 Unsecured Loans 0.00 Long Term Provisions 3.29 Current Liabilities 220.04 Trade Payables 59.53 Other Current Liabilities 46.11 Short Term Borrowings 7.13 Short Term Provisions 107.27 Total Liabilities 593.21 Net Block 138.92 Gross Block 176.03 Accumulated Depreciation 37.11 Non Current Assets 146.24 Capital Work in Progress 2.58 Non Current Investment 0.00 Long Term Loans & Adv. 4.66 Other Non Current Assets 0.08 Current Assets 446.97 Current Investments 36.84 Inventories 117.72 Sundry Debtors 144.00 Cash & Bank 70.45 Other Current Assets 77.97 Short Term Loans & Adv. 73.77 Net Current Assets 226.93 Total Assets 593.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Cash From Operating Activity 241.26 141.56 146.42 134.61 PBT 220.09 216.61 243.23 190.49 Adjustment 19.08 17.81 6.74 17.03 Changes in Working Capital 13.17 -32.89 -75.96 -72.71 Cash after chg. in Working capital 252.34 201.53 174.00 134.81 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -11.08 -59.98 -27.59 -0.20 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -263.75 -147.25 -76.03 -56.03 Net Fixed Assets -161.61 -43.01 -39.40 Net Investments -61.21 -95.51 -56.93 Others -40.93 -8.73 20.30 Cash from Financing Activity -1.99 -4.24 -56.15 -27.50 Net Cash Inflow / Outflow -24.48 -9.94 14.25 51.08 Opening Cash & Equivalents 65.44 75.37 61.13 10.05 Closing Cash & Equivalent 40.95 65.44 75.37 61.13

Description Mar 21
Cash From Operating Activity 129.28 PBT 184.66 Adjustment 17.55 Changes in Working Capital -72.73 Cash after chg. in Working capital 129.47 Interest Paid 0.00 Tax Paid -0.20 Other Direct Exp. Paid 0.00 Extra & Other Items 0.00 Cash From Investing Activity -50.73 Net Fixed Assets Net Investments Others Cash from Financing Activity -27.50 Net Cash Inflow / Outflow 51.05 Opening Cash & Equivalents 10.07 Closing Cash & Equivalent 61.13

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21
Book Value (Rs.) 48.73 39.29 30.07 19.59 ROA 14.75% 17.74% 26.11% 23.87% ROE 21.45% 26.60% 42.16% 41.67% ROCE 28.85% 36.24% 54.01% 50.03% Fixed Asset Turnover 2.81 3.24 3.50 2.83 Receivable days 106.77 118.17 99.18 105.35 Inventory Days 65.53 58.39 59.48 86.12 Payable days 48.81 59.93 73.70 128.23 Cash Conversion Cycle 123.49 116.62 84.96 63.23 Total Debt/Equity 0.00 0.00 0.00 0.15 Interest Cover 1368.05 160.39 74.71 36.89

Description Mar 21
Book Value (Rs.) 19.59 ROA 26.50% ROE 51.06% ROCE 56.68% Fixed Asset Turnover 3.31 Receivable days 96.02 Inventory Days 68.30 Payable days 120.13 Cash Conversion Cycle 44.18 Total Debt/Equity 0.15 Interest Cover 35.79

Top Investors:

government pension fund global

blue daimond properties pvt ltd

Annual Reports:

News Update:

Blue Jet Healthcare commissions production block at Ambernath Unit 2 facility
11th Dec 2024, 11:57 AM

The company has commissioned production block on December 9, 2024
Read More
Blue Jet Healthcare - Quarterly Results
29th Oct 2024, 13:01 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback